Advertisement

Growth Hormone and Obesity

  • Astrid Hjelholt
    Affiliations
    Medical Research Laboratory, Department of Clinical Medicine, Aarhus University Hospital, Aarhus N 8200, Denmark

    Medical Research Laboratory, Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus N 8200, Denmark
    Search for articles by this author
  • Morten Høgild
    Affiliations
    Medical Research Laboratory, Department of Clinical Medicine, Aarhus University Hospital, Aarhus N 8200, Denmark

    Medical Research Laboratory, Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus N 8200, Denmark
    Search for articles by this author
  • Ann Mosegaard Bak
    Affiliations
    Medical Research Laboratory, Department of Clinical Medicine, Aarhus University Hospital, Aarhus N 8200, Denmark

    Medical Research Laboratory, Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus N 8200, Denmark
    Search for articles by this author
  • Mai Christiansen Arlien-Søborg
    Affiliations
    Medical Research Laboratory, Department of Clinical Medicine, Aarhus University Hospital, Aarhus N 8200, Denmark

    Medical Research Laboratory, Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus N 8200, Denmark
    Search for articles by this author
  • Amanda Bæk
    Affiliations
    Medical Research Laboratory, Department of Clinical Medicine, Aarhus University Hospital, Aarhus N 8200, Denmark

    Medical Research Laboratory, Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus N 8200, Denmark
    Search for articles by this author
  • Niels Jessen
    Affiliations
    Steno Diabetes Center Aarhus, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, Aarhus 8200, Denmark

    Department of Clinical Pharmacology, Aarhus University Hospital, Aarhus, Denmark

    Department of Biomedicine, Aarhus University, Aarhus, Denmark
    Search for articles by this author
  • Bjørn Richelsen
    Affiliations
    Medical Research Laboratory, Department of Clinical Medicine, Aarhus University Hospital, Aarhus N 8200, Denmark

    Medical Research Laboratory, Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus N 8200, Denmark

    Steno Diabetes Center Aarhus, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, Aarhus 8200, Denmark
    Search for articles by this author
  • Steen Bønløkke Pedersen
    Affiliations
    Medical Research Laboratory, Department of Clinical Medicine, Aarhus University Hospital, Aarhus N 8200, Denmark

    Medical Research Laboratory, Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus N 8200, Denmark
    Search for articles by this author
  • Niels Møller
    Affiliations
    Medical Research Laboratory, Department of Clinical Medicine, Aarhus University Hospital, Aarhus N 8200, Denmark

    Medical Research Laboratory, Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus N 8200, Denmark
    Search for articles by this author
  • Jens Otto Lunde Jørgensen
    Correspondence
    Corresponding author. Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, Aarhus N 8200, Denmark.
    Affiliations
    Medical Research Laboratory, Department of Clinical Medicine, Aarhus University Hospital, Aarhus N 8200, Denmark

    Medical Research Laboratory, Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus N 8200, Denmark
    Search for articles by this author
Published:April 16, 2020DOI:https://doi.org/10.1016/j.ecl.2020.02.009

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Endocrinology and Metabolism Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Jorgensen J.O.
        Human growth hormone replacement therapy: pharmacological and clinical aspects.
        Endocr Rev. 1991; 12: 189-207
        • Moller N.
        • Jorgensen J.O.
        Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects.
        Endocr Rev. 2009; 30: 152-177
        • Le Roith D.
        • Bondy C.
        • Yakar S.
        • et al.
        The somatomedin hypothesis: 2001.
        Endocr Rev. 2001; 22: 53-74
        • Raben M.S.
        • Hollenberg C.H.
        Effect of growth hormone on plasma fatty acids.
        J Clin Invest. 1959; 38: 484-488
        • Rabinowitz D.
        • Zierler K.L.
        A metabolic regulating device based on the actions of human growth hormone and of insulin, singly and together, on the human forearm.
        Nature. 1963; 199: 913-915
        • Freda P.U.
        • Shen W.
        • Heymsfield S.B.
        • et al.
        Lower visceral and subcutaneous but higher intermuscular adipose tissue depots in patients with growth hormone and insulin-like growth factor I excess due to acromegaly.
        J Clin Endocrinol Metab. 2008; 93: 2334-2343
        • Jorgensen J.O.
        • Vahl N.
        • Hansen T.B.
        • et al.
        Growth hormone versus placebo treatment for one year in growth hormone deficient adults: increase in exercise capacity and normalization of body composition.
        Clin Endocrinol (Oxf). 1996; 45: 681-688
        • Copinschi G.
        • Wegienka L.C.
        • Hane S.
        • et al.
        Effect of arginine on serum levels of insulin and growth hormone in obese subjects.
        Metab Clin Exp. 1967; 16: 485-491
        • Glick S.M.
        • Roth J.
        • Yalow R.S.
        • et al.
        Immunoassay of human growth hormone in plasma.
        Nature. 1963; 199: 784-787
        • Giustina A.
        • Veldhuis J.D.
        Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human*.
        Endocr Rev. 1998; 19: 717-797
        • Beck P.
        • Koumans J.H.
        • Winterling C.A.
        • et al.
        Studies of insulin and growth hormone secretion in human obesity.
        J Lab Clin Med. 1964; 64: 654-667
        • Vahl N.
        • Jorgensen J.O.
        • Skjaerbaek C.
        • et al.
        Abdominal adiposity rather than age and sex predicts mass and regularity of GH secretion in healthy adults.
        Am J Physiol. 1997; 272: E1108-E1116
        • Rasmussen M.H.
        • Hvidberg A.
        • Juul A.
        • et al.
        Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects.
        J Clin Endocrinol Metab. 1995; 80: 1407-1415
        • Frystyk J.
        • Brick D.J.
        • Gerweck A.V.
        • et al.
        Bioactive insulin-like growth factor-I in obesity.
        J Clin Endocrinol Metab. 2009; 94: 3093-3097
        • Brismar K.
        • Fernqvist-Forbes E.
        • Wahren J.
        • et al.
        Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-3, and IGF-I in insulin-dependent diabetes.
        J Clin Endocrinol Metab. 1994; 79: 872-878
        • Cordido F.
        • Peino R.
        • Penalva A.
        • et al.
        Impaired growth hormone secretion in obese subjects is partially reversed by acipimox-mediated plasma free fatty acid depression.
        J Clin Endocrinol Metab. 1996; 81: 914-918
        • Raben M.S.
        Growth hormone.
        N Engl J Med. 1962; 266: 31-35
        • Roth J.
        • Glick S.M.
        • Yalow R.S.
        • et al.
        Hypoglycemia: a potent stimulus to secretion of growth hormone.
        Science. 1963; 140: 987-988
        • Zierler K.L.
        • Rabinowitz D.
        Roles of insulin and growth hormone, based on studies of forearm metabolism in man.
        Medicine. 1963; 42: 385-402
        • Lanning N.J.
        • Carter-Su C.
        Recent advances in growth hormone signaling.
        Rev Endocr Metab Disord. 2006; 7: 225-235
        • Nielsen C.
        • Gormsen L.C.
        • Jessen N.
        • et al.
        Growth hormone signaling in vivo in human muscle and adipose tissue: impact of insulin, substrate background, and growth hormone receptor blockade.
        J Clin Endocrinol Metab. 2008; 93: 2842-2850
        • Clasen B.F.
        • Poulsen M.M.
        • Escande C.
        • et al.
        Growth hormone signaling in muscle and adipose tissue of obese human subjects: associations with measures of body composition and interaction with resveratrol treatment.
        J Clin Endocrinol Metab. 2014; 99: E2565-E2573
        • Jorgensen J.O.
        • Jessen N.
        • Pedersen S.B.
        • et al.
        GH receptor signaling in skeletal muscle and adipose tissue in human subjects following exposure to an intravenous GH bolus.
        Am J Physiol Endocrinol Metab. 2006; 291: E899-E905
        • Moller L.
        • Dalman L.
        • Norrelund H.
        • et al.
        Impact of fasting on growth hormone signaling and action in muscle and fat.
        J Clin Endocrinol Metab. 2009; 94: 965-972
        • Vestergaard P.F.
        • Vendelbo M.H.
        • Pedersen S.B.
        • et al.
        GH signaling in skeletal muscle and adipose tissue in healthy human subjects: impact of gender and age.
        Eur J Endocrinol. 2014; 171: 623-631
        • Erman A.
        • Veilleux A.
        • Tchernof A.
        • et al.
        Human growth hormone receptor (GHR) expression in obesity: I. GHR mRNA expression in omental and subcutaneous adipose tissues of obese women.
        Int J Obes (Lond). 2011; 35: 1511-1519
        • Hogild M.L.
        • Bak A.M.
        • Pedersen S.B.
        • et al.
        Growth hormone signaling and action in obese versus lean human subjects.
        Am J Physiol Endocrinol Metab. 2019; 316: E333-E344
        • Nielsen T.S.
        • Jessen N.
        • Jorgensen J.O.
        • et al.
        Dissecting adipose tissue lipolysis: molecular regulation and implications for metabolic disease.
        J Mol Endocrinol. 2014; 52: R199-R222
        • Zechner R.
        • Zimmermann R.
        • Eichmann T.O.
        • et al.
        FAT SIGNALS--lipases and lipolysis in lipid metabolism and signaling.
        Cell Metab. 2012; 15: 279-291
        • Yang X.
        • Lu X.
        • Lombes M.
        • et al.
        The G(0)/G(1) switch gene 2 regulates adipose lipolysis through association with adipose triglyceride lipase.
        Cell Metab. 2010; 11: 194-205
        • Grahn T.H.
        • Kaur R.
        • Yin J.
        • et al.
        Fat-specific protein 27 (FSP27) interacts with adipose triglyceride lipase (ATGL) to regulate lipolysis and insulin sensitivity in human adipocytes.
        J Biol Chem. 2014; 289: 12029-12039
        • Singh M.
        • Kaur R.
        • Lee M.J.
        • et al.
        Fat-specific protein 27 inhibits lipolysis by facilitating the inhibitory effect of transcription factor Egr1 on transcription of adipose triglyceride lipase.
        J Biol Chem. 2014; 289: 14481-14487
        • Nielsen S.
        • Moller N.
        • Christiansen J.S.
        • et al.
        Pharmacological antilipolysis restores insulin sensitivity during growth hormone exposure.
        Diabetes. 2001; 50: 2301-2308
        • Segerlantz M.
        • Bramnert M.
        • Manhem P.
        • et al.
        Inhibition of the rise in FFA by Acipimox partially prevents GH-induced insulin resistance in GH-deficient adults.
        J Clin Endocrinol Metab. 2001; 86: 5813-5818
        • Segerlantz M.
        • Bramnert M.
        • Manhem P.
        • et al.
        Inhibition of lipolysis during acute GH exposure increases insulin sensitivity in previously untreated GH-deficient adults.
        Eur J Endocrinol. 2003; 149: 511-519
        • Offermanns S.
        Hydroxy-carboxylic acid receptor actions in metabolism.
        Trends Endocrinol Metab. 2017; 28: 227-236
        • Sharma V.M.
        • Vestergaard E.T.
        • Jessen N.
        • et al.
        Growth hormone acts along the PPARgamma-FSP27 axis to stimulate lipolysis in human adipocytes.
        Am J Physiol Endocrinol Metab. 2019; 316: E34-E42
        • Hjelholt A.J.
        • Lee K.Y.
        • Arlien-Søborg M.C.
        • et al.
        Temporal patterns of lipolytic regulators in adipose tissue after acute growth hormone exposure in human subjects: a randomized controlled crossover trial.
        Mol Metab. 2019; 29: 65-75
        • Kaltenecker D.
        • Mueller K.M.
        • Benedikt P.
        • et al.
        Adipocyte STAT5 deficiency promotes adiposity and impairs lipid mobilisation in mice.
        Diabetologia. 2017; 60: 296-305
        • Fain J.N.
        • Ihle J.H.
        • Bahouth S.W.
        Stimulation of lipolysis but not of leptin release by growth hormone is abolished in adipose tissue from Stat5a and b knockout mice.
        Biochem Biophys Res Commun. 1999; 263: 201-205
        • Bergan H.E.
        • Kittilson J.D.
        • Sheridan M.A.
        PKC and ERK mediate GH-stimulated lipolysis.
        J Mol Endocrinol. 2013; 51: 213-224
        • Sharma R.
        • Luong Q.
        • Sharma V.M.
        • et al.
        Growth hormone controls lipolysis by regulation of FSP27 expression.
        J Endocrinol. 2018; 239: 289-301
        • Santamarinafojo S.
        • Brewer H.B.
        Lipoprotein-lipase - structure, function and mechanism of action.
        Int J Clin Lab Res. 1994; 24: 143-147
        • Gutgsell A.R.
        • Ghodge S.V.
        • Bowers A.A.
        • et al.
        Mapping the sites of the lipoprotein lipase (LPL)-angiopoietin-like protein 4 (ANGPTL4) interaction provides mechanistic insight into LPL inhibition.
        J Biol Chem. 2019; 294: 2678-2689
        • Kersten S.
        Physiological regulation of lipoprotein lipase.
        Biochim Biophys Acta. 2014; 1841: 919-933
        • Kersten S.
        • Lichtenstein L.
        • Steenbergen E.
        • et al.
        Caloric restriction and exercise increase plasma ANGPTL4 levels in humans via elevated free fatty acids.
        Arterioscler Thromb Vasc Biol. 2009; 29: 969-974
        • Dijk W.
        • Schutte S.
        • Aarts E.O.
        • et al.
        Regulation of angiopoietin-like 4 and lipoprotein lipase in human adipose tissue.
        J Clin Lipidol. 2018; 12: 773-783
        • Dijk W.
        • Kersten S.
        Regulation of lipoprotein lipase by Angptl4.
        Trends Endocrinol Metab. 2014; 25: 146-155
        • Cinkajzlova A.
        • Mraz M.
        • Lacinova Z.
        • et al.
        Angiopoietin-like protein 3 and 4 in obesity, type 2 diabetes mellitus, and malnutrition: the effect of weight reduction and realimentation.
        Nutr Diabetes. 2018; 8: 21
        • Richelsen B.
        • Pedersen S.B.
        • Borglum J.D.
        • et al.
        Growth hormone treatment of obese women for 5 wk: effect on body composition and adipose tissue LPL activity.
        Am J Physiol. 1994; 266: E211-E216
        • Richelsen B.
        • Pedersen S.B.
        • Kristensen K.
        • et al.
        Regulation of lipoprotein lipase and hormone-sensitive lipase activity and gene expression in adipose and muscle tissue by growth hormone treatment during weight loss in obese patients.
        Metab Clin Exp. 2000; 49: 906-911
        • Ottosson M.
        • Vikman-Adolfsson K.
        • Enerback S.
        • et al.
        Growth hormone inhibits lipoprotein lipase activity in human adipose tissue.
        J Clin Endocrinol Metab. 1995; 80: 936-941
        • Clasen B.F.
        • Krusenstjerna-Hafstrom T.
        • Vendelbo M.H.
        • et al.
        Gene expression in skeletal muscle after an acute intravenous GH bolus in human subjects: identification of a mechanism regulating ANGPTL4.
        J Lipid Res. 2013; 54: 1988-1997
        • Brands M.
        • Sauerwein H.P.
        • Ackermans M.T.
        • et al.
        Omega-3 long-chain fatty acids strongly induce angiopoietin-like 4 in humans.
        J Lipid Res. 2013; 54: 615-621
        • Cahill Jr., G.F.
        Fuel metabolism in starvation.
        Annu Rev Nutr. 2006; 26: 1-22
        • Vendelbo M.H.
        • Clasen B.F.
        • Treebak J.T.
        • et al.
        Insulin resistance after a 72-h fast is associated with impaired AS160 phosphorylation and accumulation of lipid and glycogen in human skeletal muscle.
        Am J Physiol Endocrinol Metab. 2012; 302: E190-E200
        • Ho K.Y.
        • Veldhuis J.D.
        • Johnson M.L.
        • et al.
        Fasting enhances growth hormone secretion and amplifies the complex rhythms of growth hormone secretion in man.
        J Clin Invest. 1988; 81: 968-975
        • Clemmons D.R.
        • Klibanski A.
        • Underwood L.E.
        • et al.
        Reduction of plasma immunoreactive somatomedin C during fasting in humans.
        J Clin Endocrinol Metab. 1981; 53: 1247-1250
        • Wijngaarden M.A.
        • van der Zon G.C.
        • van Dijk K.W.
        • et al.
        Effects of prolonged fasting on AMPK signaling, gene expression, and mitochondrial respiratory chain content in skeletal muscle from lean and obese individuals.
        Am J Physiol Endocrinol Metab. 2013; 304: E1012-E1021
        • Grottoli S.
        • Gauna C.
        • Tassone F.
        • et al.
        Both fasting-induced leptin reduction and GH increase are blunted in Cushing's syndrome and in simple obesity.
        Clin Endocrinol (Oxf). 2003; 58: 220-228
        • Pedersen M.H.
        • Svart M.V.
        • Lebeck J.
        • et al.
        Substrate metabolism and insulin sensitivity during fasting in obese human subjects: impact of GH blockade.
        J Clin Endocrinol Metab. 2017; 102: 1340-1349
        • Mekala K.C.
        • Tritos N.A.
        Effects of recombinant human growth hormone therapy in obesity in adults: a meta analysis.
        J Clin Endocrinol Metab. 2009; 94: 130-137
        • Bak A.M.
        • Moller A.B.
        • Vendelbo M.H.
        • et al.
        Differential regulation of lipid and protein metabolism in obese vs. lean subjects before and after a 72-h fast.
        Am J Physiol Endocrinol Metab. 2016; 311: E224-E235